Appendix

 

  1. Liu S, Letada PR. Successful novel treatment of recalcitrant transient acantholytic dermatosis (Grover disease) using red light 5-aminolevulinic acid photodynamic therapy. Dermatol Surg 2013; 39:960.
  2. Norman R, Chau V. Use of etanercept in treating pruritus and preventing new lesions in Grover disease. J Am Acad Dermatol 2011; 64:796.
  3. Scheinfeld N, Mones J. Seasonal variation of transient acantholytic dyskeratosis (Grover’s disease). J Am Acad Dermatol 2006; 55:263.
  4. Breuckmann F, Appelhans C, Altmeyer P, Kreuter A. Medium-dose ultraviolet A1 phototherapy in transient acantholytic dermatosis (Grover’s disease). J Am Acad Dermatol 2005; 52:169.
  5. Hayashi H, Yokota K, Koizumi H, Shimizu H. Treatment of Grover’s disease with tacalcitol. Clin Exp Dermatol 2002; 27:160.
  6. Streit M, Paredes BE, Braathen LR, Brand CU. [Transitory acantholytic dermatosis (Grover disease). An analysis of the clinical spectrum based on 21 histologically assessed cases]. Hautarzt 2000; 51:244.
  7. Davis MD, Dinneen AM, Landa N, Gibson LE. Grover’s disease: clinicopathologic review of 72 cases. Mayo Clin Proc 1999; 74:229.
  8. Erös N, Kovács A, Károlyi Z. Successful treatment of transient acantholytic dermatosis with systemic steroids. J Dermatol 1998; 25:469.
  9. Mota AV, Correia TM, Lopes JM, Guimarães JM. Successful treatment of Grover’s disease with calcipotriol. Eur J Dermatol 1998; 8:33.
  10. Hashimoto K, Moiin A, Chang MW, Tada J. Sudoriferous acrosyringeal acantholytic disease. A subset of Grover’s disease. J Cutan Pathol 1996; 23:151.
  11. 1995 Keohane SG, Cork MJ. Treatment of Grover’s disease with calcipotriol (Dovonex). Br J    Dermatol 1995; 132:832.
  12. Heenan PJ, Quirk CJ. Transient acantholytic dermatosis. Br J Dermatol 1980; 102:515.
  13. . Helfman RJ. Grover’s disease treated with isotretinoin. Report of four cases. J Am Acad Dermatol 1985; 12:981.
  14. Paul BS, Arndt KA. Response of transient acantholytic dermatosis to photochemotherapy. Arch Dermatol 1984; 120:121.
  15. Carlos G, Anforth R, Clements A, et al. Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma. JAMA Dermatol 2015; 151:1103.
  16. Zhu HJ, Clark LN, Deloney LA, McDonald JE. Grover disease (transient acantholytic dermatosis) in acute myeloid leukemia on FDG PET/CT. Clin Nucl Med 2014; 39:e173.
  17. Anforth R, Fernandez-Peñas P, Long GV. Cutaneous toxicities of RAF inhibitors. Lancet Oncol 2013; 14:e11.
  18. Ippoliti G, Paulli M, Lucioni M, et al. Grover’s Disease after Heart Transplantation: A Case Report. Case Rep Transplant 2012; 2012:126592.
  19. Crockett JS, Burkemper NM. Grover disease (transient acantholytic dermatosis) induced by anastrozole. Cutis 2011; 88:175.
  20. Gilchrist H, Jackson S, Morse L, et al. Galli-Galli disease: A case report with review of the literature. J Am Acad Dermatol 2008; 58:299.
  21. Tscharner GG, Bühler S, Borner M, Hunziker T. Grover’s disease induced by cetuximab. Dermatology 2006; 213:37.
  22.     Boutli F, Voyatzi M, Lefaki I, et al. Transient acantholytic dermatosis (Grover’s disease) in a renal transplant patient. J Dermatol 2006; 33:178.
  23. Weedon D. Skin Pathology, Churchill Livingstone, London 2002. p.297
  24. Powell J, Sakuntabhai A, James M, et al. Grover’s disease, despite histological similarity to Darier’s disease, does not share an abnormality in the ATP2A2 gene. Br J Dermatol 2000; 143:658.
  25. Antunes I, Azevedo F, Mesquita-Guimarães J, et al. Grover’s disease secondary to ribavirin. Br J Dermatol 2000; 142:1257.
  26. French LE, Piletta PA, Etienne A, et al. Incidence of transient acantholytic dermatosis (Grover’s disease) in a hospital setting. Dermatology 1999; 198:410.
  27. Casanova JM, Pujol RM, Taberner R, et al. Grover’s disease in patients with chronic renal failure receiving hemodialysis: clinicopathologic review of 4 cases. J Am Acad Dermatol 1999; 41:1029.
  28. Guana AL, Cohen PR. Transient acantholytic dermatosis in oncology patients. J Clin Oncol 1994; 12:1703.
  29. Mahler SJ, De Villez RL, Pulitzer DR. Transient acantholytic dermatosis induced by recombinant human interleukin 4. J Am Acad Dermatol 1993; 29:206.
  30. (30 1993 Ott, A. Persistent acantholytic dermatosis in a patient with increased sensitivity to light. Zeitschrift fuer Hautkrankheiten 1993; 62:369.
  31. Andersen BL. Pyoderma gangrenosum associated with transient acantholytic dermatosis (pemphigus erythematosus-like) and paraproteinemia. Acta Derm Venereol 1981; 61:77.
  32. Antley CM, Carrington PR, Mrak RE, Smoller BR. Grover’s disease (transient acantholytic dermatosis): relationship of acantholysis to acrosyringia. J Cutan Pathol 1998; 25:545.
  33. Dodd HJ, Sarkany I. Persistent acantholytic dermatosis. Clin Exp Dermatol 1984; 9:431.
  34. http://cursoenarm.net/UPTODATE/contents/mobipreview.htm?7/5/7262/abstract/5